Management of the condition

MPS I and MPS II are managed using a combination of disease-specific therapies (see Treatment options), conventional symptomatic treatments, and surgical interventions.1

Some interventions are required to manage the life-threatening aspects of the disease (e.g. airway obstruction), whereas others are aimed at improving quality of life.2

Management of MPS I/MPS II is complex and requires numerous specialists to address disease involvement in multiple organ systems. Ideally, a designated centre specialising in lysosomal storage disorders should oversee the care of patients with MPS I/II.1,3

MPS I Disease Registry

MPS I Disease Registry

The MPS I Registry is an ongoing, observational database on MPS I disease. Many medical professionals agree that since MPS I disease is rare, accurate and complete information on the disease is especially important.

Symptom Management

Symptom Management

Learn about the symptomatic treatments used to manage disease complications and improve quality of life in patients with MPS I/MPS II.

Surgical Management

Surgical Management

Learn about the surgical interventions used in the management of MPS I/MPS II, and the complications that need to be considered.

References

  1. 1.Scarpa M, Almassy Z, Beck M, et al. (2011) Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease. Orphanet J Rare Dis 6: 72.
  2. 2.Muenzer J, Beck M, Eng CM, et al. (2009) Multidisciplinary management of Hunter syndrome. Pediatrics 124(6): e1228-1239.
  1. 3.Muenzer J, Wraith JE, Clarke LA, International Consensus Panel on M, Treatment of Mucopolysaccharidosis I. (2009) Mucopolysaccharidosis I: management and treatment guidelines. Pediatrics 123(1): 19-29.